Software issue which can lead to loss of device sensing.
ANZCDACC Management Recommendations for Boston Scientific EMBLEM S-ICD Alert
October 2023
Device: EMBLEM S-ICD Model A209 and EMBLEM MRI S-ICD A219
TGA Reference: RC-2023-RN-00850-1
Software issue which can lead to loss of device sensing.
ANZCDACC Management Recommendations for Boston Scientific EMBLEM S-ICD Alert
October 2023
Device: EMBLEM S-ICD Model A209 and EMBLEM MRI S-ICD A219
TGA Reference: RC-2023-RN-00850-1
In this Issue:
Position : Exciting PhD or Masters Opportunity at The University of Sydney and Westmead Hospital for 2024
Spontaneous Coronary Artery Dissection (SCAD) is increasingly recognised as an important cause of myocardial infarction (MI). Global estimates suggest SCAD is the most common cause of MI in women under the age of 50. Yet very little is known about the best way to prevent, diagnose and treat SCAD. The Australian New Zealand SCAD (ANZ-SCAD) Registry is being led by Associate Professor Sarah Zaman out of the Westmead Applied Research Centre (WARC) at the University of Sydney and Westmead Hospital. This national effort will recruit patients with SCAD from more than 22 hospitals across Australia and New Zealand. Data pooling with national and international SCAD cohorts will enable important research questions to be answered.
Applications are open for a PhD candidate to join the team of SCAD researchers, under the supervision of A/Prof Sarah Zaman. They will be joining the academic team at WARC, led by Director Professor Clara Chow. The research team has extensive experience in leading grants, publications, and supporting students to win awards and scholarships. Ideal applicants will have a medical degree and clinical cardiology training. To apply (or for further details), please send your CV to [email protected]. An ideal candidate would have experience in coronary angiography interpretation. To determine your eligibility for a PhD or Masters at the Faculty of Medicine and Health please visit this link.
To learn more about our centre at WARC, visit this link.
Position : PhD or Masters Opportunity in Myocardial Infarction in the Young
Myocardial infarction (MI) in young people (< age 50 years) is a devastating event that can have significant mortality, morbidity, psychological and financial effects for the individual and their families. Applications are open for a PhD or Masters candidate to join Associate Professor Sarah Zaman, and the team to research heart attacks in the young. A Young MI Registry has already begun (ethics and governance approval in place) at Westmead Hospital, Western Sydney, NSW, recruiting patients both historically and prospectively. Biomarkers, such as lipids, diabetic markers, lipoprotein(a) and high sensitivity CRP are collected. Dietary and exercise surveys are completed by prospectively consented participants. Research will focus on the different presentation features, outcomes and medical therapy as well as sex and ethnic differences and gaps in care, between young and older people with MI. Opportunity may arise to conduct prospectively clinical trials in consented participants and their families.
A PhD or master student would be joining the academic team at the Westmead Applied Research Centre, an Impact Centre of the Faculty of Medicine and Health, at the University of Sydney, under the directorship of Director Professor Clara Chow. The research team has extensive experience in leading grants, publications, and supporting students to win awards and scholarships. Ideal applicants will have clinical experience in cardiovascular disease. To apply (or for further details), please send your CV to [email protected]. Please first determine your eligibility for a PhD or Masters at the Faculty of Medicine and Health please visit this link.
To learn more about our centre at WARC, visit this link.
Position : PhD or Masters Opportunity in Diet and Heart Failure
Heart failure with reduced ejection fraction is the leading cause of hospitalisation worldwide and affects ~64 million people globally. The failing heart has been found to use ketone bodies as a significant source of energy, resulting in improvements in heart function. This has led to a theoretical basis for a benefit of ketosis in heart failure, yet clinical research in this area (such as application of a ketogenic diet) is lacking. In fact, there are incredibly few dietary trials of any kind specific to patients with heart failure, despite diet being a cornerstone of heart disease prevention and treatment.
Applications are open for a PhD or Masters candidate to join the team to research dietary interventions in treatment of patients with heart failure, under the supervision of A/Prof Sarah Zaman. They will be joining the academic team at the Westmead Applied Research Centre, an Impact Centre of the Faculty of Medicine and Health, at the University of Sydney, led by Director Professor Clara Chow. Research projects will focus on diet and heart failure, including utilisation of available longitudinal data, systematic reviews and involvement in a grant-funded prospective clinical trial of a dietary intervention in patients with heart failure. The research team has extensive experience in leading grants, publications, and supporting students to win awards and scholarships. Ideal applicants will have clinical experience in heart failure and/or in application of diet to prevent chronic disease. To apply (or for further details), please send your CV to [email protected]. To determine your eligibility for a PhD or Masters at the Faculty of Medicine and Health please visit this link.
To learn more about our centre at WARC, visit this link.
In this edition:
– Remote pulmonary artery pressure monitoring in chronic HF
– CTS associated with subsequent HF
– RAS inhibition and outcomes in HFREF and advanced kidney disease
– CRP and incident HF risk in patients with CV disease
– LBBAP vs. BVP in CRT candidates
– Torsemide vs. furosemide in hospitalised HF: symptoms and QOL
– Anaemia: effect of sacubitril-valsartan
– Neurohormonal antagonist initiation after HF hospitalisation in older adults
– Predictors of long-term CV and non-CV mortality in HFPEF
– HF pharmacotherapies and outcomes in obese vs. nonobese HFREF patients
Download the Heart Failure Research Review: Issue 79, with commentary by Prof Andrew Coats (pdf)
Bluetooth circuit component issue which can:
1. disable Bluetooth telemetry (including remote monitoring) and,
2.result in high current consumption leading to reduced device longevity.
ANZCDACC Management Recommendations for Abbott Product Defect Correction
August 2023
Device:
GALLANT™, NEUTRINO™ NXT, and ENTRANT™ ICDs and CRT-Ds manufactured prior to April 2022
(Models CDVRA500Q, CDDRA500Q, CDHFA500Q, CDVRA600Q, CDDRA600Q, CDHFA600Q, CDVRA300Q, CDDRA300Q and CDHFA300Q)
Note: No affected NEUTRINO™ NXT or ENTRANT™ ICDs and CRT-Ds were implanted in Australia.
No affected GALLANT™ or NEUTRINO™ NXT ICDs and CRT-Ds were implanted in NZ.
TGA Reference:
RC-2023-RN-00734-1
2023 Speaker Series: Heart Failure – How to welcome the fantastic four.
Presentation by Prof Andrew Sindone at the CSANZ NZ ASM June 2023.
The finalised curricula for cardiology have been approved and published on the RACP website.
2024 Transition Year
The RACP has advised that trainees who commence in the Cardiology Advanced Training program in 2024 will be enrolled under the new curricula. Existing trainees, who commenced training prior to or in 2023, will continue to follow PREP program requirements.
2024 will be a transition year introducing some new curricula components and retaining some existing work-based assessment tools from the current PREP training programs. Please see an overview of the 2024 program requirements (adult and paediatric) for the new curricula.
Information on further changes to program requirements for trainees enrolled under the new curricula, including the introduction of new work-based assessment methods, will be shared throughout next year, in preparation for 2025.